TENBAGGER-POTENTIAL: Top-Wirtschaftsmagazin adelt Biotech-Firma und bringt Vergleich mit 7,2 Mrd Übernahme! Absoluter STRONG BUY!
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
TENBAGGER-POTENTIAL***: Top-Wirtschaftsmagazin adelt Biotech-Firma und bringt Vergleich mit 7,2 Mrd Übernahme! Absoluter STRONG BUY!
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.
Is the Psychedelic Industry Following in the Footsteps of GW Pharma? By IBT Contributor Is the Psychedelic Industry Following in the Footsteps of GW Pharma Photo: Pixabay
Recently, it was announced that the cannabis industry titan, GW Pharmaceuticals , was being acquired by Jazz Pharmaceuticals for $7.2 billion. Looking back to May of 2013 when GW first went public, it was trading at $8.90 - a mere fraction of its current market valuation of over $215 per share. At this time, the thought that the small cannabidiol company would later be the target of a 10-figure acquisition was one few saw coming.
However, those who saw the future growth potential of this industry player that forever changed the global cannabis market have been handsomely rewarded for their foresight. Although it’s too late to get in on the rise and shine of GW’s stellar growth in the cannabidiol sector, new opportunities are developing within the psychedelic industry, providing investors with